Gary Nagamori joins cc-TDI Board

Gary Nagamori joins cc-TDI Board

As a bioscience futurist, Gary joins the cc-TDI Executive Board of Directors to leverage his career experience planning biomedical capital projects, shaping a bio-economic development agency and serving the NIH National Center for Research Resources.  From these...
published:  approach to NF-1 pilocytic astrocytomas

published: approach to NF-1 pilocytic astrocytomas

 Congratulations to summer intern, Cora, for her publication of “Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade Glioma“.    Cora and our collaborators David Gutmann and Yuan Pan ask the question, how do you develop better...
Bloom Syndrome Nanocourse Crowdfunding Project!

Bloom Syndrome Nanocourse Crowdfunding Project!

 Cancer in childhood is generally sporadic (not inherited)… yet sometimes there is an underlying predisposition … how does one perform health monitoring to catch the cancer(s) early? If there are issues about growth, how does one address nutrition? Are...